30 December 2011
Continuous versus interrupted suture for hepatic artery reconstruction using a loupe in living-donor liver transplantation
Yuan-Sheng TzengABCDEF, Chung-Bao HsiehABCF, Shyi-Gen ChenABCFAnn Transplant 2011; 16(4): 12-15 :: ID: 882213
Abstract
Background: Partial liver transplantation from live donors is now widely performed to compensate for the shortage of deceased donors’ organs. Operative microscopy is often used to achieve hepatic artery anastomosis. Here we report our experience of hepatic artery reconstruction using loupe magnification.
Material/Methods: We used operative microscopy (12–16× magnification) in our early experience. We changed to loupe magnification (3.5×) in 43 cases. Reconstructions were done with continuous, end-to-end anastomoses with 8-0 nylon and a 3.5× loupe was used for the arterial anastomosis.
Results: The mean follow-up time was 8 months. There were no cases of hepatic artery thrombosis.
Conclusions: Hepatic artery reconstruction in living donor liver transplantation with continuous end-to-end suturing using loupe magnification can yield good results.
Keywords: ureteral stenosis, Kidney Transplantation, clinical classification, anastomosis time, Hepatic Artery - transplantation, living donor liver transplantation
In Press
Original article
Impact of Donor-Recipient Relationship on Long-Term Outcomes in Living-Related Donor Kidney TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.945065
Original article
Urinary Chemokines CXCL9 and CXCL10 Are Non-Invasive Biomarkers of Kidney Transplant RejectionAnn Transplant In Press; DOI: 10.12659/AOT.944762
Original article
Risk Factors for Graft Failure After Penetrating Keratoplasty in Eastern China from 2018 to 2021Ann Transplant In Press; DOI: 10.12659/AOT.945388
Original article
Predictive Model for Post-Transplant Renal Fibrosis Using Ultrasound Shear Wave ElastographyAnn Transplant In Press; DOI: 10.12659/AOT.945699
Most Viewed Current Articles
05 Apr 2022 : Original article 12,955
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 10,017
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
12 Jan 2022 : Original article 9,368
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
15 Mar 2022 : Case report 7,140
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860